0001950047-24-003029.txt : 20240410
0001950047-24-003029.hdr.sgml : 20240410
20240410162214
ACCESSION NUMBER: 0001950047-24-003029
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240410
DATE AS OF CHANGE: 20240410
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 24836056
BUSINESS ADDRESS:
STREET 1: 325 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 325 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: AFEYAN NOUBAR
CENTRAL INDEX KEY: 0001222012
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O FLAGSHIP PIONEERING, INC.
STREET 2: 55 CAMBRIDGE PARKWAY, SUITE 800E
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
144
1
primary_doc.xml
144
0001222012
XXXXXXXX
LIVE
0001682852
Moderna, Inc.
001-38753
200 Technology Square
Cambridge
MA
02139
6177146500
NOUBAR B AFEYAN
Director
COMMON
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
15000
1674000.00
382073208
04/10/2024
NASDAQ
Common
05/01/2012
Private Placement
Issuer
N
15000
05/01/2012
Cash
N
10b5-1 Sales Plan for NOUBAR B AFEYAN
200 Technology Square
Cambridge
MA
02139
Common
04/03/2024
15000
1525269.00
10b5-1 Sales Plan for NOUBAR B AFEYAN
200 Technology Square
Cambridge
MA
02139
Common
03/27/2024
15000
1635864.00
10b5-1 Sales Plan for NOUBAR B AFEYAN
200 Technology Square
Cambridge
MA
02139
Common
03/20/2024
15000
1535820.00
10b5-1 Sales Plan for NOUBAR B AFEYAN
200 Technology Square
Cambridge
MA
02139
Common
03/13/2024
15000
1628031.00
04/10/2024
11/07/2023
/s/ Noubar B. Afeyan